CKD-846

DRUG2 trials

Sponsors

Chong Kun Dang Pharmaceutical

Conditions

Benign Prostate Hypertrophy(BPH)

Phase 1

A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846

CompletedNCT06110923

Chong Kun Dang PharmaceuticalBenign Prostate Hypertrophy(BPH)

Start: 2023-11-13End: 2025-03-25Updated: 2026-01-14

A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846

CompletedNCT07404735

Chong Kun Dang PharmaceuticalBenign Prostate Hypertrophy(BPH)

Start: 2026-02-23End: 2026-06-12Updated: 2026-07-21